You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華東醫藥(000963.SZ):美琪健康已積累一批意向客户及訂單
格隆匯 02-20 15:30

格隆匯2月20日丨華東醫藥(000963.SZ)於2023年2月15日14:30-16:00;2月16日11:00-11:40、14:00-15:00接受機構現場調研時表示,美琪健康已經積累了一批意向客户及訂單,將為今年下半年正式投產後的發展打下良好基礎。華仁科技以小核酸藥物和診斷試劑用核苷原料為主要業務領域,隨着全球疫情形勢的放緩,診斷試劑類業務增速較之前將有所下降。但是小核酸藥物用核苷原料領域仍然具有較大的潛力與拓展空間,華仁科技也有較為豐富的產品庫,今後將加快該類業務產業化,並在公司國際化能力的助力下,持續拓展國際市場,今年爭取比去年整體有較快的增速,不斷增強公司工業微生物核苷類業務的市場競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account